Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basil S Lewis

Showing results (231-240 of 240) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 240 results.
The New England Journal of Medicine|April 8, 2024
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial InfarctionC Michael Gibson, Danielle Duffy, Serge Korjian, et al.
Journal of the American College of Cardiology|April 8, 2024
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MIThomas J Povsic, Serge Korjian, M Cecilia Bahit, et al.
The New England Journal of Medicine|November 15, 2011
Thrombin-receptor antagonist vorapaxar in acute coronary syndromesPierluigi Tricoci, Zhen Huang, Claes Held, et al.
Gastroenterology|June 2, 2019
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or AspirinPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
Gastroenterology|May 6, 2019
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled TrialPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
The New England Journal of Medicine|August 29, 2017
Rivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseJohn W Eikelboom, Stuart J Connolly, Jackie Bosch, et al.
Circulation|June 18, 2013
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) StudyStuart J Connolly, Lars Wallentin, Michael D Ezekowitz, et al.
The New England Journal of Medicine|November 16, 2011
Dronedarone in high-risk permanent atrial fibrillationStuart J Connolly, A John Camm, Jonathan L Halperin, et al.
The Canadian Journal of Cardiology|July 30, 2017
Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) TrialJackie Bosch, John W Eikelboom, Stuart J Connolly, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 29, 2021
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapyMichael Glikson, Jens Cosedis Nielsen, Mads Brix Kronborg, et al.
Pageof 24

Showing results (231-240 of 240) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
The New England Journal of Medicine|April 8, 2024
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial InfarctionC Michael Gibson, Danielle Duffy, Serge Korjian, et al.
Journal of the American College of Cardiology|April 8, 2024
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MIThomas J Povsic, Serge Korjian, M Cecilia Bahit, et al.
The New England Journal of Medicine|November 15, 2011
Thrombin-receptor antagonist vorapaxar in acute coronary syndromesPierluigi Tricoci, Zhen Huang, Claes Held, et al.
Gastroenterology|June 2, 2019
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or AspirinPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
Gastroenterology|May 6, 2019
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled TrialPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
The New England Journal of Medicine|August 29, 2017
Rivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseJohn W Eikelboom, Stuart J Connolly, Jackie Bosch, et al.
Circulation|June 18, 2013
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) StudyStuart J Connolly, Lars Wallentin, Michael D Ezekowitz, et al.
The New England Journal of Medicine|November 16, 2011
Dronedarone in high-risk permanent atrial fibrillationStuart J Connolly, A John Camm, Jonathan L Halperin, et al.
The Canadian Journal of Cardiology|July 30, 2017
Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) TrialJackie Bosch, John W Eikelboom, Stuart J Connolly, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 29, 2021
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapyMichael Glikson, Jens Cosedis Nielsen, Mads Brix Kronborg, et al.
Pageof 24